Path2Quit Tobacco Intervention For African Americans
27 mars 2019 mis à jour par: Case Comprehensive Cancer Center
Development and Pilot Evaluation of the Path2Quit Tobacco Intervention Targeting African Americans
The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.
The study includes completing surveys and receiving text messages to help participants become tobacco free.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES Specific Aim 1: Translate a culturally specific video-based tobacco use intervention into a scalable mobile health (mhealth) format.
Specific Aim 2: Conduct a pilot study of the video-text intervention.
Study Design:
2-arm semi-pragmatic randomized design among current tobacco users
Cuyahoga Metropolitan Housing Authority residents will be randomly assigned to receive (1) the newly translated Path2Quit or (2) SmokeFreeText (NCI's publicly available, standard text messaging program) combined with brief behavioral counseling session plus 2 weeks of nicotine replacement therapy (NRT). Primary outcomes will include intervention evaluations (content and format), acceptability, coping strategies, engagement, and NRT adherence. Secondary variables will include 24-hour quit attempts and biochemically verified tobacco use abstinence at the 1-month follow-up. Exploratory mediational analyses will examine the roles of urban hassles, acculturation, neighborhood environment, ethnic discrimination, and psychological distress in intervention effects.
Type d'étude
Interventionnel
Inscription (Réel)
119
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Ohio
-
Cleveland, Ohio, États-Unis, 44106
- Case Western Reserve University, Case Comprehensive Cancer Center
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Self-identify as African American
- Either smoke at least 1 cigarettes/day or have a carbon monoxide (CO) reading of at least 4 ppm
- Consistent with SmokefreeTXT, be willing to set a quit date within the next 14 days.
- Recruited from Cleveland metropolitan housing authority or who report low income based on federal guidelines
Exclusion Criteria:
- Does not meet all of the above inclusion criteria
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Path2Quit
Culturally specific text message intervention
|
Path2Quit will deliver 20-60 second video clips by multimedia messaging service.
The message library will include 75-170 messages.
Written text messages will be limited to brief phrases to indicate the topic of the video.
Messages will be pushed to participants in the morning, in the afternoon, and 2 hours before the reported usual bedtime.
The cultural adaptations will be infused throughout the video segments.
Topics include deep structure: race and smoking in general, African American smoking statistics; norms for smoking; concerns about nicotine replacement/medication; family/collectivism; unique stressors; racism/discrimination, depression; co-morbid addiction; neighborhood/environmental influences; menthol cigarettes; race-specific weight issues and concerns; and working as a community against the tobacco industry.
|
|
Comparateur actif: SmokeFreeText
The National Cancer Institute's publicly available, standard text messaging program for tobacco cessation
|
SmokefreeTXT is a 6-8 week fully automated text-based cessation intervention.
The program is free to U.S. subscribers who have a mobile phone, and is available on smokefree.gov
or by texting "QUIT" to short code 47848.
Participants are encouraged to set a quit date within the next 14 days, followed by count-down messages leading to the quit date.
Starting on the quit date, participants receive 6 weeks of intervention text messages, and assessment questions (mood, cravings, smoking status).
The message library contains 166 messages and 41 behavior change techniques,40 which are delivered at the greatest frequency during the first 2 weeks and taper over time.
When in need of assistance, participants can text one of 3 keywords (MOOD, CRAVE, or SLIP) to receive a relevant message from the system.
Participants can opt-out by texting STOP at any time.
With informed consent, we will be able to access the SmokefreeTXT data for these participants.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Proportion of participants who abstain from smoking
Délai: At 1-month follow-up
|
Abstinence will be coded as a binary variable.
Analysis will be conducted with an intent to treat approach
|
At 1-month follow-up
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of missed nicotine replacement therapy doses
Délai: Up to 1-month follow-up
|
Measure of NRT adherence.
Number of missed doses will be recorded for each participant
|
Up to 1-month follow-up
|
|
24-Hour quit attempts
Délai: At 1-month follow-up
|
Number of times a participant quits smoking for at least 24 hours
|
At 1-month follow-up
|
|
Changes in carbon monoxide breath levels from baseline to followup
Délai: At 1-month follow-up
|
Breath carbon monoxide tests will biochemically confirm self-reported cessation
|
At 1-month follow-up
|
|
Changes in Contemplation ladder score
Délai: From baseline to up to 1-month follow-up
|
self-reported score 0-10 where a higher score indicates more readiness to quit
|
From baseline to up to 1-month follow-up
|
|
Average score of Intervention Evaluation (IRQ)
Délai: At 1-month follow-up
|
The IRQ is a 22 item scale scored 0-7 (total score 0-154) where higher scores indicate more satisfaction
|
At 1-month follow-up
|
|
Average score of smoking urges
Délai: Up to 1-month follow-up
|
This brief, 10 item scale is scores 1-7 (total score 10-70) with higher scores indicating greater agreement
|
Up to 1-month follow-up
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Average scores of Urban hassles
Délai: Changes from baseline to 1 month follow-up
|
This is a 63 item scale scored 0-5 (total score 0-315) where higher scores indicate more severe hassle
|
Changes from baseline to 1 month follow-up
|
|
Average Neighborhood Environment scale score
Délai: At Baseline
|
The neighborhood environment scale is an 18 item True or False scale
|
At Baseline
|
|
Average General Ethnic Discrimination Scale Score
Délai: At baseline
|
This is a measure of ethnic discrimination.
These 16 items are scored 1-6 (total score 16-96) with higher scores indicating greater levels of ethnic discrimination
|
At baseline
|
|
Average psychological distress score using the the perceived stress scale
Délai: At baseline
|
A ten item scale with each item scored 0-4 (total score 0-40) where higher scores indicate more stress.
Positive items are scored in reverse.
|
At baseline
|
|
Average depression score using Center for Epidemiological Studies Depression (CES-D) Scale
Délai: At baseline
|
A twenty item scale ranging from 0-60 with each item scored 0-3.
Higher scores indicate more depression
|
At baseline
|
|
Average Beliefs and Attitudes Survey Score
Délai: At baseline
|
This is a 24 item scale (total range 24-168) with each item scored 1-7.
Higher scores indicate greater levels of agreement
|
At baseline
|
|
Average Ethnic Identity Score
Délai: At baseline
|
This is based on the Multigroup Ethnic Identity Measure scale.
These five items are scored 1-4 for a total score of 5-20.
Higher scores indicate stronger ethnic identity
|
At baseline
|
|
Average Culturally Specific Interventions Expectancy Questionnaire
Délai: At baseline
|
The Culturally Specific Interventions Expectancy Questionnaire is a 2 item scale with each item ranging 1-5 (total score 2-10) where higher scores indicate greater agreement.
|
At baseline
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Monica Webb Hooper, PhD, Case Comprehensive Cancer Center
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 avril 2018
Achèvement primaire (Réel)
20 août 2018
Achèvement de l'étude (Réel)
20 août 2018
Dates d'inscription aux études
Première soumission
30 avril 2018
Première soumission répondant aux critères de contrôle qualité
11 mai 2018
Première publication (Réel)
14 mai 2018
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
28 mars 2019
Dernière mise à jour soumise répondant aux critères de contrôle qualité
27 mars 2019
Dernière vérification
1 mars 2019
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- CASE1Y18
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .